补充系统在瘤生长和转移中的作用
Tsvetan Borisov1, Dimitar Metodiev2,3,4, Dilyan Ferdinandov1,5
1Department of Neurosurgery, Faculty of Medicine, Medical University Sofia, Sofia, Bulgaria.
British journal of cancer
|November 15, 2025
概括
补体系统通过影响入侵,循环和殖民,影响癌症转移. 了解其双重作用对于开发向疗法和为临床试验选择患者至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 补体系统对于宿主防御和平衡至关重要.
- 它通过复杂的,取决于背景的机制与癌症相互作用,影响瘤生长.
- 它在癌症转移中的作用是多方面的,包括抑制和促进.
研究的目的:
- 审查补充级联对癌症转移的影响.
- 分析细胞内在补充蛋白在转移过程中的作用.
- 讨论在转移性癌症中补充系统的治疗向.
主要方法:
- 关于补充系统在癌症转移中的作用的文献综述.
- 对补体参与表皮细胞-介质细胞过渡,循环和转移前位形成的分析.
- 检查针对补充级联的治疗策略.
主要成果:
- 补充会影响局部入侵,输血,以及在流通中的生存.
- 它在扩散,转移前利基准备和殖民化中发挥作用.
- 补充剂的治疗向正在转移患者的临床试验中进行研究.
结论:
- 补体系统显著影响癌症转移的多个阶段.
- 准补体级联提供了一个有前途的治疗途径.
- 了解癌症类型的特定作用和验证生物标志物对于有效的临床应用至关重要.
相关概念视频
Complement System
9.7K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
9.7K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Selectins
4.1K
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
4.1K


